β-Cyclodextrin derivatives that inhibit anthrax lethal toxin

Vladimir A. Karginov, Adiamseged Yohannes, Tanisha M. Robinson, Nour Eddine Fahmi, Kenneth Alibek, Sidney Hecht

Research output: Contribution to journalArticle

39 Citations (Scopus)

Abstract

Recently, we demonstrated that simultaneous blocking of bacterial growth by antibiotics and inhibition of anthrax toxin action with antibodies against protective antigen were beneficial for the treatment of anthrax. The present study examined the hypothesis that blocking the pore formed by protective antigen can inhibit the action of anthrax toxin. The potential inhibitors were chosen by a structure-based design using β-cyclodextrin as the starting molecule. Several β-cyclodextrin derivatives were evaluated for their ability to protect RAW 264.7 cells from the action of anthrax lethal toxin. Per-substituted aminoalkyl derivatives displayed inhibitory activity and were protective against anthrax lethal toxin action at low micromolar concentrations. These results provide the basis for a structure-based drug discovery program, with the goal of identifying new drug candidates for anthrax treatment.

Original languageEnglish (US)
Pages (from-to)33-40
Number of pages8
JournalBioorganic and Medicinal Chemistry
Volume14
Issue number1
DOIs
StatePublished - Jan 1 2006
Externally publishedYes

Fingerprint

Cyclodextrins
Antigens
Anthrax
Anti-Bacterial Agents
Derivatives
Molecules
Antibodies
Drug Discovery
Pharmaceutical Preparations
anthrax toxin
Growth

Keywords

  • β-Cyclodextrin derivatives
  • Anthrax treatment
  • Lethal toxin inhibitors

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Organic Chemistry
  • Drug Discovery
  • Pharmaceutical Science

Cite this

β-Cyclodextrin derivatives that inhibit anthrax lethal toxin. / Karginov, Vladimir A.; Yohannes, Adiamseged; Robinson, Tanisha M.; Fahmi, Nour Eddine; Alibek, Kenneth; Hecht, Sidney.

In: Bioorganic and Medicinal Chemistry, Vol. 14, No. 1, 01.01.2006, p. 33-40.

Research output: Contribution to journalArticle

Karginov, VA, Yohannes, A, Robinson, TM, Fahmi, NE, Alibek, K & Hecht, S 2006, 'β-Cyclodextrin derivatives that inhibit anthrax lethal toxin', Bioorganic and Medicinal Chemistry, vol. 14, no. 1, pp. 33-40. https://doi.org/10.1016/j.bmc.2005.07.054
Karginov, Vladimir A. ; Yohannes, Adiamseged ; Robinson, Tanisha M. ; Fahmi, Nour Eddine ; Alibek, Kenneth ; Hecht, Sidney. / β-Cyclodextrin derivatives that inhibit anthrax lethal toxin. In: Bioorganic and Medicinal Chemistry. 2006 ; Vol. 14, No. 1. pp. 33-40.
@article{d876b384b5124633ab8ece299b36793e,
title = "β-Cyclodextrin derivatives that inhibit anthrax lethal toxin",
abstract = "Recently, we demonstrated that simultaneous blocking of bacterial growth by antibiotics and inhibition of anthrax toxin action with antibodies against protective antigen were beneficial for the treatment of anthrax. The present study examined the hypothesis that blocking the pore formed by protective antigen can inhibit the action of anthrax toxin. The potential inhibitors were chosen by a structure-based design using β-cyclodextrin as the starting molecule. Several β-cyclodextrin derivatives were evaluated for their ability to protect RAW 264.7 cells from the action of anthrax lethal toxin. Per-substituted aminoalkyl derivatives displayed inhibitory activity and were protective against anthrax lethal toxin action at low micromolar concentrations. These results provide the basis for a structure-based drug discovery program, with the goal of identifying new drug candidates for anthrax treatment.",
keywords = "β-Cyclodextrin derivatives, Anthrax treatment, Lethal toxin inhibitors",
author = "Karginov, {Vladimir A.} and Adiamseged Yohannes and Robinson, {Tanisha M.} and Fahmi, {Nour Eddine} and Kenneth Alibek and Sidney Hecht",
year = "2006",
month = "1",
day = "1",
doi = "10.1016/j.bmc.2005.07.054",
language = "English (US)",
volume = "14",
pages = "33--40",
journal = "Bioorganic and Medicinal Chemistry",
issn = "0968-0896",
publisher = "Elsevier Limited",
number = "1",

}

TY - JOUR

T1 - β-Cyclodextrin derivatives that inhibit anthrax lethal toxin

AU - Karginov, Vladimir A.

AU - Yohannes, Adiamseged

AU - Robinson, Tanisha M.

AU - Fahmi, Nour Eddine

AU - Alibek, Kenneth

AU - Hecht, Sidney

PY - 2006/1/1

Y1 - 2006/1/1

N2 - Recently, we demonstrated that simultaneous blocking of bacterial growth by antibiotics and inhibition of anthrax toxin action with antibodies against protective antigen were beneficial for the treatment of anthrax. The present study examined the hypothesis that blocking the pore formed by protective antigen can inhibit the action of anthrax toxin. The potential inhibitors were chosen by a structure-based design using β-cyclodextrin as the starting molecule. Several β-cyclodextrin derivatives were evaluated for their ability to protect RAW 264.7 cells from the action of anthrax lethal toxin. Per-substituted aminoalkyl derivatives displayed inhibitory activity and were protective against anthrax lethal toxin action at low micromolar concentrations. These results provide the basis for a structure-based drug discovery program, with the goal of identifying new drug candidates for anthrax treatment.

AB - Recently, we demonstrated that simultaneous blocking of bacterial growth by antibiotics and inhibition of anthrax toxin action with antibodies against protective antigen were beneficial for the treatment of anthrax. The present study examined the hypothesis that blocking the pore formed by protective antigen can inhibit the action of anthrax toxin. The potential inhibitors were chosen by a structure-based design using β-cyclodextrin as the starting molecule. Several β-cyclodextrin derivatives were evaluated for their ability to protect RAW 264.7 cells from the action of anthrax lethal toxin. Per-substituted aminoalkyl derivatives displayed inhibitory activity and were protective against anthrax lethal toxin action at low micromolar concentrations. These results provide the basis for a structure-based drug discovery program, with the goal of identifying new drug candidates for anthrax treatment.

KW - β-Cyclodextrin derivatives

KW - Anthrax treatment

KW - Lethal toxin inhibitors

UR - http://www.scopus.com/inward/record.url?scp=27744524135&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=27744524135&partnerID=8YFLogxK

U2 - 10.1016/j.bmc.2005.07.054

DO - 10.1016/j.bmc.2005.07.054

M3 - Article

C2 - 16169738

AN - SCOPUS:27744524135

VL - 14

SP - 33

EP - 40

JO - Bioorganic and Medicinal Chemistry

JF - Bioorganic and Medicinal Chemistry

SN - 0968-0896

IS - 1

ER -